Multivitamins: Almost Worthless, But Maybe Not Quite


From Emily Oster:

Many medical studies show positive health effects from higher vitamin levels. The only problem? These studies often can’t tease out the effect of the vitamins from the effect of other factors, such as generally healthy living. Studies that attempt to do this typically show no impact from vitamin use — or only a very tiny one on a small subset of people. The truth is that for most people, vitamin supplementation is simply a waste of time.

Every once in a while I vaguely decide that maybe I’d feel better if I took vitamins. So I buy a bottle of multivitamins and take them for a while. What usually happens next is that I come across yet another in the long parade of news pieces and blog posts reminding me that vitamin supplements are useless. And then I stop again.

I am, needless to say, not talking about specific vitamin supplements recommended by my doctor for a specific condition. I’m talking about the routine use of vitamin supplements. And Oster is right: study after study shows that they’re all but worthless.

And yet! There’s also this from a study released a couple of years ago:

Men who took a daily multivitamin had a statistically significant lower rate of cancer than those who took the placebo (17.0 versus 18.3 events per 1000 person-years). Although mortality was lower as well, it wasn’t statistically significant (4.9 versus 5.6 events per 1000 person-year).

This was an extremely large study, well done, with amazing follow-up. You can’t dismiss it easily.

That’s Aaron Carroll, not generally someone who succumbs to faddish nonsense. The study in question isn’t perfect, but as he says, it’s pretty good. And it suggests that, in fact, multivitamins help reduce the incidence of cancer in men, especially those with a baseline history of cancer. And they’re cheap. So if you happen to be male, maybe multivitamins are worth it after all.

OUR DEADLINE MATH PROBLEM

It’s risky, but also unavoidable: A full one-third of the dollars that we need to pay for the journalism you rely on has to get raised in December. A good December means our newsroom is fully staffed, well-resourced, and on the beat. A bad one portends budget trouble and hard choices.

The December 31 deadline is drawing nearer, and if we’re going to have any chance of making our goal, we need those of you who’ve never pitched in before to join the ranks of MoJo donors.

We simply can’t afford to come up short. There is no cushion in our razor-thin budget—no backup, no alternative sources of revenue to balance our books. Corporations and powerful people with deep pockets will never sustain the fierce journalism we do. That’s why we need you to show up for us right now.

payment methods

OUR DEADLINE MATH PROBLEM

It’s risky, but also unavoidable: A full one-third of the dollars that we need to pay for the journalism you rely on has to get raised in December. A good December means our newsroom is fully staffed, well-resourced, and on the beat. A bad one portends budget trouble and hard choices.

The December 31 deadline is drawing nearer, and if we’re going to have any chance of making our goal, we need those of you who’ve never pitched in before to join the ranks of MoJo donors.

We simply can’t afford to come up short. There is no cushion in our razor-thin budget—no backup, no alternative sources of revenue to balance our books. Corporations and powerful people with deep pockets will never sustain the fierce journalism we do. That’s why we need you to show up for us right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate